✦ LIBER ✦

Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells Serve as Both Targets and Effectors for the Complete Angiogenic Cytokine, VEGF

✍ Scribed by John R. Haynie

Book ID: 113738166
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 43 KB
Volume: 66
Category: Article
ISSN: 1531-5053
DOI: 10.1016/j.joms.2008.05.091

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Human head and neck squamous cell carcin

Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF

✍ Meng Tong; Brandon Lloyd; Ping Pei; Susan R. Mallery 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 329 KB

## Abstract Former vascular endothelial growth factor (VEGF)–head and neck squamous cell carcinoma (HNSCC) studies have focused on VEGF's contributions toward tumor‐associated angiogenesis. Previously, we have shown that HNSCC cells produce high levels of VEGF. We therefore hypothesized that VEGF s

RAD51C – A new human cancer susceptibili

RAD51C – A new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC)

✍ Scheckenbach, Kathrin; Baldus, Stephan E.; Balz, Vera; Freund, Marcel; Pakropa, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Human Papillomavirus Infection as a Risk

Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck

✍ Mork, Jon; Lie, A. Kathrine; Glattre, Eystein; Clark, Sarah; Hallmans, Göran; Je 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 179 KB

Natural killer (NK) cells as effectors o

Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck

✍ Myung-Whun Sung; Satoshi Yasumura; Jonas T. Johnson; Guus A. M. S. Van Dongen; T 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 939 KB

In patients with cancer, antibody-dependent cellular cytotoxicity (ADCC) may be used as a laboratory test or for enhancing immunotherapy with murine monoclonal or chimeric mouse/ human anti-tumor antibodies (mMAbs or cMAbs, respectively). We have established an ADCC assay with lgG, cMAb SF-25, using

SP232 – Stat3 as a therapeutic target fo

SP232 – Stat3 as a therapeutic target for endothelial cells in the treatment of head and neck squamous cell carcinoma

✍ Jonah Klein; Seungwon Kim 📂 Article 📅 2009 🏛 SAGE Publications 🌐 English ⚖ 72 KB

Examining expression of folate receptor

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug

✍ Nabil F. Saba; Xu Wang; Susan Müller; Mourad Tighiouart; Kwangjae Cho; Shuming N 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB 👁 1 views

## Abstract ## Background Nanotechnology‐based drug delivery approaches may help increase therapeutic efficacy and decrease side effects of chemotherapeutics. We investigated expression levels of folate receptor in squamous cell carcinoma of the head and neck (SCCHN) to evaluate folate receptor as